Position in GILD
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$607,695
-$65,462 QoQ
Shares Held
4,810
-0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,296
of 2,275 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fort Sheridan Advisors LLC holds $58,603,256 across 10 Drug Manufacturers - General names. GILD ranks #8 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
68,432 | $17,220,228 | |
| 2 | JNJ |
Johnson & Johnson
|
50,589 | $12,848,088 | |
| 3 | MRK |
Merck & Co., Inc.
|
98,070 | $12,601,995 | |
| 4 | LLY |
ELI LILLY & Co
|
5,314 | $6,373,771 | |
| 5 | AMGN |
Amgen Inc
|
8,505 | $3,079,830 | |
| 6 | PFE |
Pfizer Inc
|
120,987 | $2,913,366 | |
| 7 | NVS |
Novartis AG
|
13,967 | $2,188,908 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
4,810 | $607,695 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $607,695 | 4,810 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $673,157 | 4,830 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $897,229 | 7,310 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $811,410 | 7,310 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $844,275 | 7,615 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $855,501 | 7,635 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $711,249 | 7,700 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $649,676 | 7,749 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $582,430 | 8,489 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $650,679 | 8,883 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $798,920 | 9,862 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $746,477 | 9,961 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $767,617 | 9,960 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $805,804 | 9,712 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $607,302 | 7,074 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $455,025 | 7,376 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $456,034 | 7,378 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $435,055 | 7,318 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $517,709 | 7,130 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $613,632 | 8,785 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $618,913 | 8,988 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $419,642 | 6,493 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $376,359 | 6,460 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $395,569 | 6,260 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $481,644 | 6,260 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $536,103 | 7,171 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||